• US stock market daily report (August 10, 2015, Monday)

    Day traders and active traders hit the mother-load on Friday, and traded in awe Monday as shares of Aquinox Pharmaceuticals Inc. (AQXP - Nasdaq) fed the short term traders like it was 1999.

    Canadian pharmaceutical company Aquinox shares hit an intraday high of $11.68 on Friday, after reporting positive secondary endpoints results from a Phase 2 leadership trial with AQX-1125 in patients with bladder pain syndrome/interstitial cystitis.

    Shares of Aquinox ended Fridays trading session up 582% at $10.42, after closing at $1.79 on Thursdays trading session.

    On Monday, shares skyrocketed again, hosting a gain of over 180% into early afternoon trading, setting a new historical 52 week high of $55.75. Over 13 million shares exchanged hands as of early afternoon trading. AQXP previous record high was $14 recorded on March 12, 2014.

    Hitting a new 52 week high of 55.75 helped investors, daytraders and short term active traders rake in hefty trading profits on the stock with an average daily trading volume of just over 1 million shares.

    In a recent U.S. Securities and Exchange Commission (SEC) filing, Baker Bros came forward and announced a 40% stake - nearly 4.27 million shares for a total of 39.8% ownership in Aquinox.

    Trading was halted at least six times in the first two hours of trading on Monday, after Aquinox crossed circuit-breaker limits that aim to reduce volatility.

    Contributed by Millennium Traders
About us
StockMarketsReview.com provides news coverage, analysis and researches for world stock markets, commodities and currencies. We publish articles provided by experts of leading brokerage and investment companies. At our website investors can find daily, weekly and monthly reports, news, recommendations on the IPOs and fundamental analysis for stocks which are currently traded at the stock exchange.